Intensity Therapeutics, Inc. INTS
Set alert
3.43 USD +0.03 +0.88%
At close
3.43 0.00 0.00%
Pre-market · Nov 3, 5:33 AM ET
3.23 Day range 3.47
3.00 52-week range 15.75
- YTD
- -66.54%
- 1 year
- -77.87%
- Open
- 3.41
- Prev close
- 3.40
- Mkt cap
- 11.20M
- Vol
- 5.58K
- Avg vol
- 24.12K
- EPS
- -3.89
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.23
- High
- 3.47
- Forward P/E
- -1.66
- Beta
- 0.00
- Short ratio
- 3.05
- Inst. own
- 12.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 2.90
- 200-d avg
- 4.10
- 1y target
- 10.00
YTD chart
Events in this range
- Feb 19, 2026Split: 1 for 25
Signals (35)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 28, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| SMA: Bearish | Jul 30, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| RSI: Overbought | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| RSI: Oversold | Jun 16, 2026 | 4 months ago |
| MACD: Sell Signal | May 29, 2026 | 5 months ago |
| RSI: Oversold | May 27, 2026 | 5 months ago |
Newest 20 of 35.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.00 +191.5% upside
Now 3.43
- Target (low)
- 4.00
- Target (mean)
- 10.00
- Target (high)
- 16.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 31, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Jul 11, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| May 16, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Mar 21, 2024 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Nov 14, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Aug 24, 2023 | Benchmark | Reiterated | Speculative Buy | Speculative Buy |
| Jul 18, 2023 | Benchmark | Initiated | — | Speculative Buy |